• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Inify Laboratories

Less than 1K followers

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Overview
Investor consensus

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.

Read more
Market cap
-
Turnover
-
Revenue
24.05M
EBIT %
-316.54 %
P/E
-
Dividend yield-%
-
Financial calendar
26.8
2026

Interim report Q2'26

28.10
2026

Interim report Q3'26

24.2
2027

Annual report '26

All
Press releases
ShowingAll content types

Regulatory press release6/8/2026, 1:13 PM

INIFY: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics

Inify Laboratories
Regulatory press release6/8/2026, 1:13 PM

Inify Laboratories AB: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics

Inify Laboratories
Regulatory press release5/27/2026, 8:16 AM

INIFY: Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory

Inify Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/27/2026, 8:15 AM

Inify Laboratories AB: Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory

Inify Laboratories
Regulatory press release5/21/2026, 6:00 AM

Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026

Inify Laboratories
Regulatory press release5/21/2026, 6:00 AM

Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026

Inify Laboratories
Regulatory press release4/29/2026, 6:00 AM

Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden

Inify Laboratories
Regulatory press release4/29/2026, 6:00 AM

Inify Laboratories AB: Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden

Inify Laboratories
Regulatory press release4/24/2026, 3:49 PM

INIFY: Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics

Inify Laboratories
Regulatory press release4/24/2026, 3:49 PM

Inify Laboratories AB: Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics

Inify Laboratories
Regulatory press release4/15/2026, 6:05 AM

Inify Laboratories - notice of Annual General Meeting on May 20, 2026

Inify Laboratories
Regulatory press release4/15/2026, 6:05 AM

Inify Laboratories AB: Inify Laboratories - notice of Annual General Meeting on May 20, 2026

Inify Laboratories
Regulatory press release4/15/2026, 6:00 AM

Inify Laboratories AB: Inify Laboratories - Annual Report 2025

Inify Laboratories
Regulatory press release3/24/2026, 6:23 PM

Inify Laboratories - New share capital registered

Inify Laboratories
Regulatory press release3/24/2026, 6:23 PM

Inify Laboratories AB: Inify Laboratories - New share capital registered

Inify Laboratories
Regulatory press release2/25/2026, 7:00 AM

Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Inify Laboratories
Regulatory press release2/25/2026, 7:00 AM

Inify Laboratories AB: Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Inify Laboratories
Regulatory press release1/30/2026, 8:30 AM

Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories
Regulatory press release1/30/2026, 8:30 AM

Inify Laboratories AB: Correction: Inify Laboratories - mandatory notification of trade

Inify Laboratories
Regulatory press release1/27/2026, 5:51 PM

Inify Laboratories - mandatory notification of trade

Inify Laboratories